Related Experiment Video
Updated: Apr 11, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Identification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters
Wooseong Kim1, Annie L Conery2, Rajmohan Rajamuthiah3
1Division of Infectious Diseases, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.
Abstract:
Persisters are a subpopulation of normal bacterial cells that show tolerance to conventional antibiotics. Persister cells are responsible for recalcitrant chronic infections and new antibiotics effective against persisters would be a major development in the treatment of these infections. Using the reporter dye SYTOX Green that only stains cells with permeabilized membranes, we developed a fluorescence-based screening assay in a 384-well format for identifying compounds that can kill methicillin-resistant Staphylococcus aureus (MRSA) persisters. The assay proved robust and suitable for high throughput screening (Z`-factor: >0.7). In screening a library of hits from a previous screen, which identified compounds that had the ability to block killing of the nematode Caenorhabditis by MRSA, we discovered that the low molecular weight compound NH125, a bacterial histidine kinase inhibitor, kills MRSA persisters by causing cell membrane permeabilization, and that 5 μg/mL of the compound can kill all cells to the limit of detection in a 108 CFU/mL culture of MRSA persisters within 3h. Furthermore, NH125 disrupts 50% of established MRSA biofilms at 20 μg/mL and completely eradicates biofilms at 160 μg/mL. Our results suggest that the SYTOX Green screening assay is suitable for large-scale projects to identify small molecules effective against MRSA persisters and should be easily adaptable to a broad range of pathogens that form persisters. Since NH125 has strong bactericidal properties against MRSA persisters and high selectivity to bacteria, we believe NH125 is a good anti-MRSA candidate drug that should be further evaluated.
Insights
Researchers identified a new compound, NH125, that effectively kills antibiotic-tolerant persister cells in Methicillin-resistant Staphylococcus aureus (MRSA) infections. This discovery offers a promising new strategy for treating persistent bacterial infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Persister cells are a subpopulation of bacteria tolerant to antibiotics, contributing to chronic and difficult-to-treat infections.
- New therapeutic strategies are needed to effectively eliminate these persister cells.
Purpose of the Study:
- To develop a high-throughput screening assay for identifying compounds that kill Methicillin-resistant Staphylococcus aureus (MRSA) persisters.
- To discover novel compounds effective against MRSA persisters and biofilms.
Main Methods:
- A fluorescence-based screening assay using SYTOX Green dye was developed in a 384-well format.
- The assay was used to screen a library of compounds, identifying potential persister-killing agents.
- The efficacy of identified compounds against MRSA persisters and biofilms was evaluated.
Main Results:
- A robust and high-throughput screening assay (Z`-factor: >0.7) was established.
- The compound NH125, a histidine kinase inhibitor, was identified as a potent killer of MRSA persisters by inducing membrane permeabilization.
- NH125 demonstrated bactericidal activity, eradicating persisters at 5 μg/mL within 3 hours and disrupting/eradicating MRSA biofilms at higher concentrations.
Conclusions:
- The SYTOX Green assay is suitable for large-scale screening to find small molecules effective against MRSA persisters.
- NH125 shows significant potential as an anti-MRSA drug candidate due to its bactericidal properties and selectivity.
- The assay is adaptable for identifying compounds against persisters in other bacterial pathogens.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Antimicrobial Effectiveness
Mechanism of Antibiotic Resistance in MRSA

